Financhill
Back

BioLine Rx 10K Form

Sell
32

BLRX
BioLine Rx

Last Price:
0.43
Seasonality Move:
4.46%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BLRX News And Ratings

See the #1 stock for the next 7 days that we like better than BLRX

BLRX Financial Statistics

Sales & Book Value

Annual Sales: $4.8M
Cash Flow: $-11.36M
Price / Cash Flow: 0
Annual Sales: $0.17
Price / Book: 2.44

Profitability

EPS (TTM): -0.45350
Net Income (TTM): $-30.12M
Gross Margin: $1.11M
Return on Equity: -202.27%
Return on Assets: -51.59%

BioLine Rx Earnings Forecast

Key BioLine Rx Financial Ratios

  • The Gross Profit Margin over the past 9 years for BLRX is 23.08%.
  • The Selling, General & Administrative Expenses for BLRX have been equal to 650.63% of Gross Profit Margin.
  • The Research & Development expenses have been 260.81% of Revenue.
  • The Interest Expense is -3.54% of Operating Income.
  • The Net Earning history of BLRX is -1,262.79% of Total Revenues.
  • Per Share Earnings over the last 14 years have been positive in 9 years.

BioLine Rx Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: BLRX
CUSIP: 09071M
Website: biolinerx.com

Debt

Debt-to-Equity Ratio: 2.11
Current Ratio: 1.61
Quick Ratio: 1.44

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BLRX Technical Analysis vs Fundamental Analysis

Sell
32
BioLine Rx (BLRX) is a Sell

Is BioLine Rx a Buy or a Sell?

  • BioLine Rx stock is rated a Sell
    The current BioLine Rx [BLRX] share price is $0.43. The Score for BLRX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.